Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zwahlen

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
JAMIA Open|October 28, 2024
Predicting the sample size of randomized controlled trials using natural language processingPaul Windisch, Fabio Dennstädt, Carole Koechli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 25, 2024
Thyroid avoidance in treatment planning for breast cancer patients irradiated to the supraclavicular nodesAlessandro Clivio, Daniel R Zwahlen, Sonja Koch, et al.
Frontiers in Oncology|July 17, 2023
Re-irradiation for head and neck cancer: outcome and toxicity analysis using a prospective single institution databaseChiara Scolari, André Buchali, Achim Franzen, et al.
Schweizer Archiv Fur Tierheilkunde|November 7, 2007
[Reported adverse reactions due to veterinary drugs in 2006]C R Müntener, L Bruckner, B Gassner, et al.
Cancers|September 18, 2020
Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic ReviewPaul Windisch, Daniel R Zwahlen, Stefan A Koerber, et al.
EJNMMI Research|February 19, 2021
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic reviewPaul Windisch, Daniel R Zwahlen, Frederik L Giesel, et al.
International Archives of Allergy and Immunology|July 1, 1996
Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthmaS C Bischoff, R Zwahlen, M Stucki, et al.
BMC Urology|February 3, 2024
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validationPaul Windisch, Ivo Becker, Hongjian Tang, et al.
Radiation Oncology (London, England)|November 12, 2014
PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markersChristoph Oehler, Stephanie Lang, Peter Dimmerling, et al.
Cancers|July 14, 2023
Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate BedLuca Hanke, Hongjian Tang, Christina Schröder, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
JAMIA Open|October 28, 2024
Predicting the sample size of randomized controlled trials using natural language processingPaul Windisch, Fabio Dennstädt, Carole Koechli, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 25, 2024
Thyroid avoidance in treatment planning for breast cancer patients irradiated to the supraclavicular nodesAlessandro Clivio, Daniel R Zwahlen, Sonja Koch, et al.
Frontiers in Oncology|July 17, 2023
Re-irradiation for head and neck cancer: outcome and toxicity analysis using a prospective single institution databaseChiara Scolari, André Buchali, Achim Franzen, et al.
Schweizer Archiv Fur Tierheilkunde|November 7, 2007
[Reported adverse reactions due to veterinary drugs in 2006]C R Müntener, L Bruckner, B Gassner, et al.
Cancers|September 18, 2020
Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic ReviewPaul Windisch, Daniel R Zwahlen, Stefan A Koerber, et al.
EJNMMI Research|February 19, 2021
Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic reviewPaul Windisch, Daniel R Zwahlen, Frederik L Giesel, et al.
International Archives of Allergy and Immunology|July 1, 1996
Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthmaS C Bischoff, R Zwahlen, M Stucki, et al.
BMC Urology|February 3, 2024
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validationPaul Windisch, Ivo Becker, Hongjian Tang, et al.
Radiation Oncology (London, England)|November 12, 2014
PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markersChristoph Oehler, Stephanie Lang, Peter Dimmerling, et al.
Cancers|July 14, 2023
Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate BedLuca Hanke, Hongjian Tang, Christina Schröder, et al.
Pageof 11